ESC Premium Access

When should we add PCSK-9 inhibitors?


About the speaker

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
34 presentations
1 follower

3 more presentations in this session

Treatment intensity in primary and secondary prevention? The role of precision medicine.

Speaker: Professor J. Deanfield (London, GB)


Should we address other lipid/lipoproteins besides LDL-C?

Speaker: Professor R. Frikke-Schmidt (Copenhagen, DK)


Is there a place for anti-inflammatory medication in clinical practice?

Speaker: Professor K. Ray (London, GB)


Access the full session

Lipid-lowering therapy: how to tailor treatment to your patient

Speakers: Professor S. Nicholls, Professor J. Deanfield, Professor R. Frikke-Schmidt, Professor K. Ray

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk